EVIglance 对比 TELLAPRIALBI 的使用情况和统计数据

Clinical trials form the basis for clinical decision making and future research trends. Due to the steadily increasing number of published studies, there is a need to focus on high-quality studies. EVIglance provides you with a systematic and living evidence map for medical topics including meta-analyses and free of charge. The advantages of EVIglance are: - Systematic and updated overview on a specific field in medicine - Direct link to all existing systematic reviews and randomized-controlled trials in a specific field - Living meta-analyses which are immediately updated when a new trial becomes available - Processed data from trials for your own systematic review - Benchmarks for your research
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection. Combining these scores, the APRI+ALBI score provides even better performance of assessment and prediction regarding 30-day-mortality after surgery. TELLAPRIALBI allows you to - enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels) - automatically compute APRI, ALBI and APRI+ALBI scores for comparative review - select from a variety of tumor types together with the respective extent of resection and - view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score. The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the users device and no information is stored, transmitted or shared by the app. TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and Howto Health GmbH. It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by Howto Health GmbH.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

EVIglance与TELLAPRIALBI排名比较

对比 EVIglance 与 TELLAPRIALBI 在过去 28 天内的排名趋势

排名

没有可用的数据

EVIglance 对比 TELLAPRIALBI 的排名,按国家/地区比较

对比 EVIglance 与 TELLAPRIALBI 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
EVIglance VS.
TELLAPRIALBI

十二月 19, 2024